Skip to main content

Table 1 Patients characteristics

From: MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience

No

Age

Diagnosis

Reason for BT boost ineligibility

Outcome after ≥ 3 months after therapy

1

33

Recurrent cervical cancer

Infiltration of the pelvic wall. Tumor extended from the recto-sigmoidal junction to the upper third of the vagina with infiltration of the uterus, the right ovary and the rectum

PD 6 months after therapy with distant metastasis

2

47

Recurrent cervical cancer

Infiltration of pelvic wall, presacral region, through the sciatic foramen. Erosion of the ilium and infiltration of the sciatic nerve

PR

3

56

Recurrent cervical cancer

Infiltration of the urinary bladder wall. The tumor circumscribed the left ureter and extended to the sigmoid

CR of local tumor. One lymph node metastasis inguinal right; outside radiation field

4

56

Recurrent cervical cancer

Infiltration of the pelvic wall and left ureter

CR

5

37

Recurrent cervical cancer

Infiltration of the pelvic floor, ureter, paravaginal region and sigmoid

CR

6

70

Recurrent vaginal cancer

Infiltration of the pelvic floor

CR

7

43

Recurrent vaginal cancer

Contact with rectosigmoid junction and left ovary

PR

8

63

Recurrent vaginal cancer

Infiltration of the urethra

CR

9

57

1st diagnosis of cervical cancer

Infiltration of the pelvic floor and rectum (cT4)

CR

10

82

1st diagnosis of cervical cancer

not suitable for anesthesia

PD, distant metastases 7 months after therapy

  1. PD progressive disease, PR partial remission, CR complete remission